13F
中

MGX METAGENOMI THERAPEUTICS INC

2026Q1 · CUSIP 59102M104 · Sector: Healthcare & Biotech

Neutral · No signal
Holders
47
Δ holders QoQ
-9
Breadth percentile
Top 85%
Whale holders
27
Δ whales
-4
Inst. holding value
$9M
New positions
5
Closed positions
14
Price momentum (1Q)
—
Put / Call
0/0

Breadth history (34 quarters)

2024Q2: Δ+5 · h=54 2024Q3: Δ+12 · h=66 2024Q4: Δ+12 · h=78 2025Q1: Δ+1 · h=79 2025Q2: Δ-9 · h=70 2025Q3: Δ-12 · h=58 2025Q4: Δ-2 · h=56 2026Q1: Δ-9 · h=47 2024Q2: holders=54 2024Q3: holders=66 2024Q4: holders=78 2025Q1: holders=79 2025Q2: holders=70 2025Q3: holders=58 2025Q4: holders=56 2026Q1: holders=47 -12 -6 +0 +6 +12 426383 24Q224Q324Q425Q125Q225Q325Q426Q1 Δ holders (bar) Holders (line)

Past Lit Events & Aftermath 0 lit events

No lit events in history

Options Sentiment

Put holders
0
QoQ: 0
Call holders
0
QoQ: 0

See methodology →

Fundamentals

PE (TTM)
—
EPS (TTM)
$-2.29
EPS YoY
—
Revenue (TTM)
$0.0B
Revenue YoY
-50.7%
Quarterly Revenue & EPS (4Y)
2023-03-31: $9M 2023-06-30: $11M 2023-09-30: $12M 2023-12-31: $12M 2024-03-31: $11M 2024-06-30: $20M 2024-09-30: $12M 2024-12-31: $10M 2025-03-31: $4M 2025-06-30: $9M 2025-09-30: $9M 2025-12-31: $4M 2026-03-31: $1M 2024-06-30: EPS -0.29 2024-09-30: EPS -0.51 2024-12-31: EPS -0.37 2025-03-31: EPS -0.68 2025-06-30: EPS -0.54 2025-09-30: EPS -0.55 2025-12-31: EPS -0.59 2026-03-31: EPS -0.61 0M 10M 20M $M -0.75 -0.37 0.00 2023202420252026 Revenue EPS

Quarterly figures; EPS split-adjusted, early quarters hidden when not calibrable

As of 2026-03-31 · SEC filings (XBRL)